Adtran powers 30% of Openreach’s Full Fibre network with future-proof SDX OLT platform
Adtran today announced that Openreach has passed 8.6 million premises using its open and disaggregated SDX optical line terminal (OLT) platform, managed by Mosaic CP. The milestone highlights the rapid growth of Openreach’s fiber network and the role of Adtran’s technology in enabling high-speed broadband expansion across the UK. By leveraging Adtran’s solutions, Openreach is advancing its goal of delivering next-generation connectivity to homes and businesses nationwide. Adtran’s disaggregated SDX platform of switches, OLTs, ONTs and software provides the scalability, energy efficiency, deployment speed and operational automation needed to help Openreach meet surging bandwidth demands.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250225178623/en/
Adtran’s fiber access technology is helping Openreach drive high-speed connectivity throughout the UK. (Photo: Business Wire)
“Extending our full-fiber network is a key step in our mission to build a faster, more reliable digital future for the UK,” said Trevor Linney, director of network technology at Openreach. “This expansion, with 5.2 million premises ready for service and 1 million connected customers using Adtran technology, is part of our long-term investment to upgrade the nation’s infrastructure, moving from legacy copper to a robust, future-ready fiber network. Our partnership with Adtran and its fiber access technology began with their data center-inspired leaf-spine architecture, which has been instrumental in supporting our rollout that has already passed 17 million premises. This approach enabled us to efficiently connect more than 650 communication provider partners at scale across large cities, towns and rural areas throughout the UK. Our network will be the backbone of the nation’s economy for decades to come, supporting millions more customers as we continue to expand across the country.”
Adtran’s technology and services are playing a key role in expanding high-speed connectivity, enabling Openreach to deploy GPON and XGS-PON-ready capability on the same platform while reducing costs and accelerating fiber rollout. Mosaic CP’s open architecture optimizes operations by automating service provisioning, assurance and performance monitoring. The SDX platform’s scalability allows Openreach to use a common leaf-spine architecture, from street cabinets serving a few hundred premises to major exchanges serving tens of thousands.
With unmatched density and energy efficiency, the SDX platform outperforms traditional architectures, reducing space by over 30% and cutting power consumption by 50% compared to previous-generation OLTs. This efficiency enables faster deployment in existing exchanges and – combined with Adtran’s installation and build services and recently expanded distribution center in York – helps Openreach keep its ambitious fiber expansion plans on schedule. Openreach will continue to reap the benefits as the platform expands beyond FTTP to Ethernet services for businesses and enterprises, delivering even greater savings in space and power over legacy Ethernet solutions.
“Openreach’s rollout is setting new benchmarks for speed and scale,” commented Stuart Broome, GM of EMEA sales at Adtran. “Across its full FTTP network, Openreach has now passed 17 million premises, with our technology central to that growth. This deployment represents the largest and fastest rollout of our disaggregated SDX OLTs and switches to date. By integrating our SDX 6330 OLT featuring Combo PON technology and our comprehensive Mosaic CP management platform, Openreach is rapidly growing its fiber footprint while seamlessly preparing for XGS-PON. Our solution is designed to accelerate deployments, simplify operations and ensure a sustainable fiber infrastructure. We look forward to continuing our collaboration to connect millions more homes and businesses throughout the UK.”
About Adtran
ADTRAN Holdings, Inc. (NASDAQ: ADTN and FSE: QH9) is the parent company of Adtran, Inc., a leading global provider of open, disaggregated networking and communications solutions that enable voice, data, video and internet communications across any network infrastructure. From the cloud edge to the subscriber edge, Adtran empowers communications service providers around the world to manage and scale services that connect people, places and things. Adtran solutions are used by service providers, private enterprises, government organizations and millions of individual users worldwide. ADTRAN Holdings, Inc. is also the largest shareholder of Adtran Networks SE, formerly ADVA Optical Networking SE. Find more at Adtran, LinkedIn and X.
Published by
ADTRAN Holdings, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250225178623/en/
Contacts
For media
Gareth Spence
+44 1904 699 358
public.relations@adtran.com
For investors
Peter Schuman
+1 256 963 6305
investor.relations@adtran.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 08:44:00 CET | Press Release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
Incyte Japan Announces Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer22.12.2025 08:42:00 CET | Press Release
Incyte Biosciences Japan G.K. today announced the Japan Ministry of Health, Labour and Welfare (MHLW) approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of advanced squamous cell carcinoma of the anal canal (SCAC). "Today's approval marks a significant milestone for patients with advanced anal cancer in Japan – the MHLW’s approval of Zynyz as the first and only first-line treatment for SCAC," said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan G.K. "By offering combination therapy with chemotherapy, Zynyz provides a vital new path forward for patients facing this challenging disease, addressing a significant unmet need in cancer care for patients with SCAC and their families." The approval was based on data from the Phase 3 POD1UM-303/InterAACT2 trial evaluating Zynyz in combination with platinum-based chemotherapy (carboplatin-paclitaxel) in adult patients with metastatic or inoperable
GBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published22.12.2025 08:30:00 CET | Press Release
Regulatory News: Mexedia S.p.A. Società Benefit (Euronext Growth Paris: ALMEX, ISIN IT0005450819) (“Mexedia” or the “Company”) informs that the analyst coverage report prepared by GBC AG – one of the leading independent financial research firms in Germany –, developed within an issuer-sponsored research framework, has been completed and is now publicly available. The report follows the re-initiation of analyst coverage by GBC AG previously communicated by the Company and is based exclusively on publicly available information. The content, assumptions and conclusions of the report are solely attributable to the analyst. The GBC AG analyst coverage report is available on the Company’s official website at the following address: https://mexedia.com/en/financial-statements-and-reports/ and on the analyst’s website. Daniel Gilcher, Chief Financial Officer of Mexedia S.p.A. Società Benefit, stated: “The completion and publication of the analyst coverage report by GBC AG represents the conclus
Hisense Joins HEVC Advance Patent Pool22.12.2025 03:06:00 CET | Press Release
Access Advance LLC, the global leader in video codec patent pool licensing, today announced that Hisense Group Holdings Co., Ltd. has joined the HEVC Advance Patent Pool as a Licensee. Hisense joins the recent additions to the Access Advance patent pools, including Xiaomi, MSI, Transsion, and expanded relationships with Huawei, HP and Sharp. Hisense, headquartered in Qingdao, China, is one of the world's largest television manufacturers, with a global presence spanning Asia, Europe, the Americas, and beyond. The company's products reach consumers in more than 160 countries and regions worldwide. "We are pleased to welcome Hisense to the HEVC Advance Patent Pool," said Peter Moller, CEO of Access Advance. "This agreement is the result of extensive engagement between our teams over a considerable period of time. Hisense's decision to join the pool reflects a recognition that transparent, efficient licensing solutions benefit both innovators and implementers across the video technology ec
Textron Aviation Defense Secures First Contract to Deliver Beechcraft T-6 Texan II Integrated Training System to Japan22.12.2025 02:00:00 CET | Press Release
Textron Aviation Defense LLC, a Textron Inc. (NYSE:TXT) company, today announced that the company has finalized its first contract to deliver the Beechcraft T-6JP Texan II integrated training system to Japan’s Air Self-Defense Force (JASDF), in coordination with Kanematsu Corporation. The initial contract includes two Beechcraft T-6JP Texan II aircraft and instructor pilot and aircraft maintainer training materials. Deliveries of the first two aircraft are scheduled for 2029, with additional contracts anticipated. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221925354/en/ The Beechcraft T-6 Texan II is designed and manufactured by Textron Aviation Defense LLC, a wholly owned subsidiary of Textron Aviation Inc. “This contract marks a pivotal step in strengthening Japan’s next-generation pilot training capabilities,” said Travis Tyler, president and CEO, Textron Aviation Defense. “We’re honored to support the Japan Air Se
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom